Cost-effectiveness Analysis with Influence Diagrams

被引:12
|
作者
Arias, M. [1 ]
Diez, F. J. [1 ]
机构
[1] UNED, Dept Artificial Intelligence, Madrid 28040, Spain
关键词
Cost-benefit analysis; cost-effectiveness analysis; decision trees; influence diagrams; INFERENCE; HEALTH;
D O I
10.3414/ME13-01-0121
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Background: Cost-effectiveness analysis (CEA) is used increasingly in medicine to determine whether the health benefit of an intervention is worth the economic cost. Decision trees, the standard decision modeling technique for non-temporal domains, can only perform CEA for very small problems. Objective: To develop a method for CEA in problems involving several dozen variables. Methods: We explain how to build influence diagrams (IDs) that explicitly represent cost and effectiveness. We propose an algorithm for evaluating cost-effectiveness IDs directly, i.e., without expanding an equivalent decision tree. Results: The evaluation of an ID returns a set of intervals for the willingness to pay separated by cost-effectiveness thresholds and, for each interval, the cost, the effectiveness, and the optimal intervention. The algorithm that evaluates the ID directly is in general much more efficient than the brute-force method, which is in turn more efficient than the expansion of an equivalent decision tree. Using OpenMarkov, an open-source software tool that implements this algorithm, we have been able to perform CEAs on several IDs whose equivalent decision trees contain millions of branches. Conclusion: IDs can perform CEA on large problems that cannot be analyzed with decision trees.
引用
收藏
页码:353 / 358
页数:6
相关论文
共 50 条
  • [21] Cost-effectiveness analysis in minimally invasive spine surgery
    Al-Khouja, Lutfi T.
    Baron, Eli M.
    Johnson, J. Patrick
    Kim, Terrence T.
    Drazin, Doniel
    NEUROSURGICAL FOCUS, 2014, 36 (06) : E4
  • [22] Cost-effectiveness analysis of intensive hypertension control in China
    Xie, Xiaolei
    He, Tianhua
    Kang, Jian
    Siscovick, David S.
    Li, Yan
    Pagan, Jose A.
    PREVENTIVE MEDICINE, 2018, 111 : 110 - 114
  • [23] Cost-effectiveness of coronary clinical intervention: a retrospective analysis
    Pillai, K. R.
    Fernandes, Sunaina G.
    JOURNAL OF PUBLIC HEALTH-HEIDELBERG, 2020, 28 (04): : 375 - 381
  • [24] A Framework of Cost-Effectiveness Analysis for Alternative Energy Strategies
    Qin, Ruwen
    Grasman, Scott E.
    Long, Suzanna
    Lin, Yaqin
    Thomas, Mathew
    ENGINEERING MANAGEMENT JOURNAL, 2012, 24 (04) : 18 - 35
  • [25] On valuing morbidity, cost-effectiveness analysis, and being rude
    Kenkel, D
    JOURNAL OF HEALTH ECONOMICS, 1997, 16 (06) : 749 - 757
  • [26] Methadone maintenance and HIV prevention: A cost-effectiveness analysis
    Zaric, GS
    Brandeau, ML
    Barnett, PG
    MANAGEMENT SCIENCE, 2000, 46 (08) : 1013 - 1031
  • [27] Cost-Effectiveness of Down Syndrome Screening Paradigms
    Caughey, Aaron B.
    Kaimal, Anjali J.
    Odibo, Anthony O.
    CLINICS IN LABORATORY MEDICINE, 2010, 30 (03) : 629 - +
  • [28] Behavioral interventions and cost-effectiveness analysis
    Wagner, TH
    Goldstein, MK
    PREVENTIVE MEDICINE, 2004, 39 (06) : 1208 - 1214
  • [29] AN ANALYSIS OF THE COST-EFFECTIVENESS OF THE IMPLANTABLE DEFIBRILLATOR
    KUPPERMANN, M
    LUCE, BR
    MCGOVERN, B
    PODRID, PJ
    BIGGER, JT
    RUSKIN, JN
    CIRCULATION, 1990, 81 (01) : 91 - 100
  • [30] Cost-effectiveness analysis with risk aversion
    Zivin, JG
    HEALTH ECONOMICS, 2001, 10 (06) : 499 - 508